Open original FDA record ↗Recall record
- FDA identifier
- Z-2615-2026
- Company in FDA record
- Medline Industries, LP
- FDA classification date
- Jul 2, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
Expansion of RES 98277. Specific lots of reprocessed catheters may contain small particles of residual material. If devices with residual particulates on patient-contacting surfaces are used, there is a potential risk of an inflammatory response or systemic infection. If particulate were to dislodge during use and contact circulating blood or the heart, it may produce a granulomatous reaction or thrombus formation, which may lead to cerebral or pulmonary embolism, or deep vein thrombosis.
Source facts
- Action
- This is an expansion of recall RES 98277. On May 15, 2026, firm notified affected consignee via letter titled "URGENT MEDICAL DEVICE RECALL". All affected product has expired. The consignee was instructed to quarantine all affected product and destroy it.
- Initiated
- 2026-05-15
- Root cause
- Under Investigation by firm
- Distribution
- US Nationwide distribution in the state of TX.
- Recall number
- Z-2615-2026
- Recall status
- Open, Classified
- CDRH record ID
- 220873
- FDA classified
- 2026-07-02
- Recall event number
- 99122